Literature DB >> 8861958

PAX8-mediated activation of the wt1 tumor suppressor gene.

M Dehbi1, J Pelletier.   

Abstract

The developing renal system has long been exploited to study the regulation of gene expression during mesenchymal-epithelial transitions. Several transcription factors, including WT1 and PAX8, are expressed early in nephrogenesis and play a key role in this process. The expression of PAX8 occurs in the induced mesenchyme of the developing kidney prior to the upregulation of WT1 levels in the same cells. In this report, we assessed whether the Pax-8 gene product resides upstream of wt1 in a common regulatory pathway. Transfection studies, as well as gel-shift assays, indicate that PAX8 transactivates wt1 through elements within a 38 bp conserved motif, present in human and murine promoters. Two PAX8 isoforms, generated by alternative splicing at the C-terminus and previously thought to lack transactivation potential, were found to be capable of activating wt1 expression. We also demonstrate that the endogenous wt1 promoter can be upregulated by exogenously supplied PAX8, suggesting that a function of PAX8 during mesenchymal--epithelial cell transition in renal development is to induce wt1 gene expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8861958      PMCID: PMC452155     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  59 in total

Review 1.  Pax in development.

Authors:  P Gruss; C Walther
Journal:  Cell       Date:  1992-05-29       Impact factor: 41.582

2.  Improved expression vectors for eukaryotic promoter/enhancer studies.

Authors:  J L Fridovich-Keil; J M Gudas; I B Bryan; A B Pardee
Journal:  Biotechniques       Date:  1991-11       Impact factor: 1.993

3.  Transcriptional regulation of the human Wilms' tumor gene (WT1). Cell type-specific enhancer and promiscuous promoter.

Authors:  G C Fraizer; Y J Wu; S M Hewitt; T Maity; C C Ton; V Huff; G F Saunders
Journal:  J Biol Chem       Date:  1994-03-25       Impact factor: 5.157

4.  Identification of a Pax paired domain recognition sequence and evidence for DNA-dependent conformational changes.

Authors:  J Epstein; J Cai; T Glaser; L Jepeal; R Maas
Journal:  J Biol Chem       Date:  1994-03-18       Impact factor: 5.157

5.  Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus.

Authors:  K M Call; T Glaser; C Y Ito; A J Buckler; J Pelletier; D A Haber; E A Rose; A Kral; H Yeger; W H Lewis
Journal:  Cell       Date:  1990-02-09       Impact factor: 41.582

6.  Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping.

Authors:  M Gessler; A Poustka; W Cavenee; R L Neve; S H Orkin; G A Bruns
Journal:  Nature       Date:  1990-02-22       Impact factor: 49.962

7.  Cell-type-specific expression of the rat thyroperoxidase promoter indicates common mechanisms for thyroid-specific gene expression.

Authors:  H Francis-Lang; M Price; M Polycarpou-Schwarz; R Di Lauro
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

8.  Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor.

Authors:  G R Dressler; E C Douglass
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

9.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06

10.  Pax8, a murine paired box gene expressed in the developing excretory system and thyroid gland.

Authors:  D Plachov; K Chowdhury; C Walther; D Simon; J L Guenet; P Gruss
Journal:  Development       Date:  1990-10       Impact factor: 6.868

View more
  17 in total

1.  Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding.

Authors:  E C Roberts; R W Deed; T Inoue; J D Norton; A D Sharrocks
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

Review 2.  Candidate genes and potential targets for therapeutics in Wilms' tumour.

Authors:  Christopher Blackmore; Max J Coppes; Aru Narendran
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

3.  The loss of Hoxa5 function causes estrous acyclicity and ovarian epithelial inclusion cysts.

Authors:  Gaëlle Gendronneau; Olivier Boucherat; Josée Aubin; Margot Lemieux; Lucie Jeannotte
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

4.  Overlapping DNA recognition motifs between Sp1 and a novel trans-acting factor within the wt1 tumour suppressor gene promoter.

Authors:  M T Discenza; M Dehbi; J Pelletier
Journal:  Nucleic Acids Res       Date:  1997-11-01       Impact factor: 16.971

5.  The role of NF-kappaB in the regulation of the expression of wilms tumor suppressor gene WT1.

Authors:  Y Chen; B R Williams
Journal:  Gene Expr       Date:  2000

6.  Deficiency in WT1-targeting microRNA-125a leads to myeloid malignancies and urogenital abnormalities.

Authors:  N Tatsumi; N Hojo; O Yamada; M Ogawa; Y Katsura; S Kawata; E Morii; H Sakamoto; R Inaba; A Tsuda; I Fukuda; N Moriguchi; H Hasuwa; M Okabe; F Fujiki; S Nishida; H Nakajima; A Tsuboi; Y Oka; N Hosen; H Sugiyama; Y Oji
Journal:  Oncogene       Date:  2015-05-11       Impact factor: 9.867

Review 7.  Thyroid transcription factors in development, differentiation and disease.

Authors:  Lara P Fernández; Arístides López-Márquez; Pilar Santisteban
Journal:  Nat Rev Endocrinol       Date:  2014-10-28       Impact factor: 43.330

Review 8.  Cell and molecular biology of kidney development.

Authors:  Kimberly J Reidy; Norman D Rosenblum
Journal:  Semin Nephrol       Date:  2009-07       Impact factor: 5.299

9.  Pax8 has a key role in thyroid cell differentiation.

Authors:  M Pasca di Magliano; R Di Lauro; M Zannini
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

10.  Genome-wide analysis of Pax8 binding provides new insights into thyroid functions.

Authors:  Sergio Ruiz-Llorente; Enrique Carrillo Santa de Pau; Ana Sastre-Perona; Cristina Montero-Conde; Gonzalo Gómez-López; James A Fagin; Alfonso Valencia; David G Pisano; Pilar Santisteban
Journal:  BMC Genomics       Date:  2012-04-24       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.